Skip to main content
Premium Trial:

Request an Annual Quote

Athletigen Raises $1.6M in Seed Funding

NEW YORK (GenomeWeb) – Athletigen Technologies announced today that it has raised approximately $1.6 million in seed funding, which the firm will use to advance its sports-focused direct-to-consumer genetic analysis service.

Athletigen markets a $199 kit that customers use to provide the company with a saliva sample that is analyzed for 850,000 genetic variants, which the firm claims can influence human athletic performance. Under a deal signed in October, Athletigen uses Affymetrix's Axiom genotyping platform for the analysis. 

With the new seed money, Athletigen said it aims to expand usage of its service with a focus on athletes preparing for the 2016 Summer Olympics.

The financing was led by Exponential Partners, which now has a representative on Athletigen's board of directors. Also participating in the funding round were existing investors Ray Muzyka and Content Bloom.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.